• NALTREXONE CHEMBL19019 FDA Approved

    Alternate Names:

    Naltrexone
    EN-1639A [As Hydrochloride]
    Vivitrol
    Trexan
    Trexal
    Revia
    EN-1639A
    Celupan
    C679
    135650687
    1639
    (4R,4AS,7AR,12BS)-3-(CYCLOPROPYLMETHYL)-4A,9-DIHYDROXY-2,4,5,6,7A,13-HEXAHYDRO-1H-4,12-METHANOBENZOFURO[3,2-E]ISOQUINOLINE-7-ONE;HYDROCHLORIDE
    (4R,4AS,7AR,12BS)-3-(CYCLOPROPYLMETHYL)-4A,9-BIS(OXIDANYL)-2,4,5,6,7A,13-HEXAHYDRO-1H-4,12-METHANOBENZOFURO[3,2-E]ISOQUINOLINE-7-ONE;HYDROCHLORIDE
    (1S,5R,13R,17S)-4-(CYCLOPROPYLMETHYL)-10,17-DIHYDROXY-12-OXA-4-AZAPENTACYCLO[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]OCTADECA-7(18),8,10-TRIEN-14-ONE
    (1S,5R,13R,17S)-4-(CYCLOPROPYLMETHYL)-10,17-DIHYDROXY-12-OXA-4-AZAPENTACYCLO[9.6.1.0;{1,13}.0;{5,17}.0;{7,18}]OCTADECA-7,9,11(18)-TRIEN-14-ONE
    (1S,5R,13R,17S)-4-(CYCLOPROPYLMETHYL)-10,17-DIHYDROXY-12-OXA-4-AZAPENTACYCLO[9.6.1.0(1),(1)(3).0?,(1)?.0?,(1)?]OCTADECA-7(18),8,10-TRIEN-14-ONE
    AB00174152-14
    88088-EP2305648A1
    88088-EP2298776A1
    88088-EP2298761A1
    88088-EP2275420A1
    88088-EP2270005A1
    W-5099
    FT-0696752
    PL006614
    HY-76711
    AN-12941
    NCGC00024427-05
    NCGC00024427-04
    NCGC00024427-03
    MCULE-7032963403
    CS-0880
    TOX21_112007_1
    AKOS015994596
    DAP000379
    BDBM50000787
    TOX21_112007
    CYCLOPROPYLMETHYL(DIHYDROXY)[?]ONE
    MOLPORT-004-920-221
    DQCKKXVULJGBQN-XFWGSAIBSA-N
    CHEBI:121459
    CID_5485201
    BDBM60212
    ZINC1773
    GTPL1639
    5S6W795CQM
    SCHEMBL34681
    CHEMBL142
    PUBCHEM24168
    CID5360515
    NCGC00162274-02
    (-)NALTREXONE
    REVIAREG
    REVEZ
    NEKSI
    ARROP
    NALTAX
    OPIZONE
    NARCORAL
    NALTREXON
    NALERONA
    DEPENDEX
    ANTAXON
    ADEPEND
    ABERNIL
    NALTREKSON
    SMR000058767
    16676-29-2
    CAS-16590-41-3
    NALTREXONE BASE ANHYDROUS
    17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXMORPHINAN-6-ONE, (5.ALPHA.)-
    3,14-DIHYDROXY-17-(CYCLOPROPYLMETHYL)-4,5ALPHA-EPOXYMORPHINAN-6-ONE
    MLS002153483
    MLS000069607
    BRD-K88172511-310-03-8
    DSSTOX_GSID_46313
    DSSTOX_RID_81532
    DSSTOX_CID_26313
    MORPHINAN-6-ONE, 17-(CYCLOPROPYLMETHYL)-4,5-ALPHA-EPOXY-3,14-DIHYDROXY-
    D05113
    C07253
    17-(CYCLOPROPYLMETHYL)-4,5ALPHA-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
    LS-92094
    SMP1_000206
    DB00704
    PDSP2_000847
    MORPHINAN-6-ONE, 17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXY-, (5ALPHA)-
    HMS2089O11
    PTI-555
    17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
    BPBIO1_000146
    SPBIO_002071
    NALTREXONE [USAN:INN:BAN]
    NALTREXONE [USAN:BAN:INN]
    BIDD:GT0405
    BSPBIO_000132
    BRN 3596648
    HS-0002
    UM-792
    EINECS 240-649-9
    PRESTWICK3_000116
    PRESTWICK2_000116
    PRESTWICK1_000116
    PRESTWICK0_000116
    NALTREXONE (USAN/INN)
    N-CYCLOPROPYLMETHYL-14-HYDROXYDIHYDROMORPHINONE
    HSDB 6750
    CHEBI:7465
    CCRIS 3506
    NEMEXIN
    NALTREXONE (REVIA)
    VIVITROL (TN)
    UNII-5S6W795CQM
    MORVIVA
    NALTREXONA [INN-SPANISH]
    NALTREXONUM [INN-LATIN]
    N-CYCLOPROPYLMETHYLNOROXYMORPHONE
    NALTREXONA
    NALTREXONUM
    DEPADE
    16590-41-3
    VIVITREX
    5360515
    9462